Soumit Roy
Stock Analyst at Jones Trading
(1.43)
# 3,339
Out of 4,840 analysts
42
Total ratings
18.75%
Success rate
-9.75%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Soumit Roy
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TARA Protara Therapeutics | Initiates: Buy | $21 | $3.16 | +564.56% | 1 | May 22, 2025 | |
| AVBP ArriVent BioPharma | Initiates: Buy | $40 | $20.69 | +93.33% | 1 | May 20, 2025 | |
| ELVN Enliven Therapeutics | Maintains: Buy | $36 → $27 | $16.00 | +68.75% | 2 | May 16, 2025 | |
| ACRV Acrivon Therapeutics | Downgrades: Hold | n/a | $1.10 | - | 2 | May 16, 2025 | |
| ONCY Oncolytics Biotech | Downgrades: Hold | n/a | $0.40 | - | 2 | May 16, 2025 | |
| MURA Mural Oncology | Downgrades: Hold | n/a | $2.63 | - | 2 | Mar 25, 2025 | |
| CRVO CervoMed | Upgrades: Buy | $15 | $7.96 | +88.44% | 3 | Mar 13, 2025 | |
| NUVB Nuvation Bio | Initiates: Buy | $10 | $2.24 | +346.43% | 1 | Mar 12, 2025 | |
| BEAM Beam Therapeutics | Upgrades: Buy | $34 | $17.03 | +99.65% | 2 | Mar 10, 2025 | |
| INAB IN8bio | Upgrades: Buy | $1.2 | $0.14 | +733.91% | 4 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $32 | $2.26 | +1,315.93% | 1 | Jan 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.61 | - | 1 | Nov 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $9 | $6.31 | +42.63% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $17 | $5.78 | +194.12% | 1 | Oct 31, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $13 | $1.65 | +687.88% | 1 | Sep 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6 → $4 | $0.70 | +471.51% | 2 | Sep 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $2.13 | - | 2 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $0.32 | - | 1 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $22 → $26 | $7.82 | +232.48% | 2 | Apr 17, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $70 | $24.24 | +188.78% | 1 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $10 | $35.25 | -71.63% | 2 | Apr 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $4.38 | - | 2 | May 23, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $80 | $9.19 | +770.51% | 1 | Apr 19, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | n/a | $1.77 | - | 2 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $320 | $8.00 | +3,900.00% | 1 | Nov 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $810 | $4.90 | +16,430.61% | 1 | Feb 24, 2021 |
Protara Therapeutics
May 22, 2025
Initiates: Buy
Price Target: $21
Current: $3.16
Upside: +564.56%
ArriVent BioPharma
May 20, 2025
Initiates: Buy
Price Target: $40
Current: $20.69
Upside: +93.33%
Enliven Therapeutics
May 16, 2025
Maintains: Buy
Price Target: $36 → $27
Current: $16.00
Upside: +68.75%
Acrivon Therapeutics
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $1.10
Upside: -
Oncolytics Biotech
May 16, 2025
Downgrades: Hold
Price Target: n/a
Current: $0.40
Upside: -
Mural Oncology
Mar 25, 2025
Downgrades: Hold
Price Target: n/a
Current: $2.63
Upside: -
CervoMed
Mar 13, 2025
Upgrades: Buy
Price Target: $15
Current: $7.96
Upside: +88.44%
Nuvation Bio
Mar 12, 2025
Initiates: Buy
Price Target: $10
Current: $2.24
Upside: +346.43%
Beam Therapeutics
Mar 10, 2025
Upgrades: Buy
Price Target: $34
Current: $17.03
Upside: +99.65%
IN8bio
Feb 11, 2025
Upgrades: Buy
Price Target: $1.2
Current: $0.14
Upside: +733.91%
Jan 28, 2025
Initiates: Buy
Price Target: $32
Current: $2.26
Upside: +1,315.93%
Nov 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $1.61
Upside: -
Oct 31, 2024
Initiates: Buy
Price Target: $9
Current: $6.31
Upside: +42.63%
Oct 31, 2024
Initiates: Buy
Price Target: $17
Current: $5.78
Upside: +194.12%
Sep 17, 2024
Initiates: Buy
Price Target: $13
Current: $1.65
Upside: +687.88%
Sep 11, 2024
Maintains: Buy
Price Target: $6 → $4
Current: $0.70
Upside: +471.51%
Jul 1, 2024
Downgrades: Hold
Price Target: n/a
Current: $2.13
Upside: -
May 15, 2024
Downgrades: Hold
Price Target: n/a
Current: $0.32
Upside: -
Apr 17, 2024
Maintains: Buy
Price Target: $22 → $26
Current: $7.82
Upside: +232.48%
Apr 16, 2024
Initiates: Buy
Price Target: $70
Current: $24.24
Upside: +188.78%
Apr 11, 2024
Upgrades: Buy
Price Target: $10
Current: $35.25
Upside: -71.63%
May 23, 2023
Downgrades: Hold
Price Target: n/a
Current: $4.38
Upside: -
Apr 19, 2023
Initiates: Buy
Price Target: $80
Current: $9.19
Upside: +770.51%
Nov 16, 2022
Downgrades: Hold
Price Target: n/a
Current: $1.77
Upside: -
Nov 8, 2022
Initiates: Buy
Price Target: $320
Current: $8.00
Upside: +3,900.00%
Feb 24, 2021
Initiates: Buy
Price Target: $810
Current: $4.90
Upside: +16,430.61%